<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="de">
	<id>https://ddn.pluspedia.org/w/index.php?action=history&amp;feed=atom&amp;title=Alpha-1-Antitrypsin</id>
	<title>Alpha-1-Antitrypsin - Versionsgeschichte</title>
	<link rel="self" type="application/atom+xml" href="https://ddn.pluspedia.org/w/index.php?action=history&amp;feed=atom&amp;title=Alpha-1-Antitrypsin"/>
	<link rel="alternate" type="text/html" href="https://ddn.pluspedia.org/w/index.php?title=Alpha-1-Antitrypsin&amp;action=history"/>
	<updated>2026-08-24T12:22:41Z</updated>
	<subtitle>Versionsgeschichte dieser Seite in PlusPedia</subtitle>
	<generator>MediaWiki 1.43.3</generator>
	<entry>
		<id>https://ddn.pluspedia.org/w/index.php?title=Alpha-1-Antitrypsin&amp;diff=28184&amp;oldid=prev</id>
		<title>Ossip Groth: Die Seite wurde neu angelegt: „Entstehender Artikel {| class=&quot;wikitable&quot; | | bgcolor=&quot;#dfdfdf&quot; | &#039;&#039;&#039;Siehe auch&#039;&#039;&#039; | align=&quot;left&quot; width=&quot;800&quot; | |- | bgcolor=&quot;#d…“</title>
		<link rel="alternate" type="text/html" href="https://ddn.pluspedia.org/w/index.php?title=Alpha-1-Antitrypsin&amp;diff=28184&amp;oldid=prev"/>
		<updated>2010-02-20T12:23:28Z</updated>

		<summary type="html">&lt;p&gt;Die Seite wurde neu angelegt: „&lt;a href=&quot;/wiki/Datei:Pptpdtjpg1.png&quot; title=&quot;Datei:Pptpdtjpg1.png&quot;&gt;miniatur|Entstehender Artikel&lt;/a&gt; {| class=&amp;quot;wikitable&amp;quot; | | bgcolor=&amp;quot;#dfdfdf&amp;quot; | &amp;#039;&amp;#039;&amp;#039;Siehe auch&amp;#039;&amp;#039;&amp;#039; | align=&amp;quot;left&amp;quot; width=&amp;quot;800&amp;quot; | |- | bgcolor=&amp;quot;#d…“&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Neue Seite&lt;/b&gt;&lt;/p&gt;&lt;div&gt;[[Datei:pptpdtjpg1.png|miniatur|Entstehender Artikel]]&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; |&lt;br /&gt;
| bgcolor=&amp;quot;#dfdfdf&amp;quot; | &amp;#039;&amp;#039;&amp;#039;Siehe auch&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
| align=&amp;quot;left&amp;quot; width=&amp;quot;800&amp;quot; |&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;#dfdfdf&amp;quot; | &amp;#039;&amp;#039;&amp;#039;Freie Übersichtsartikel&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
| align=&amp;quot;left&amp;quot; width=&amp;quot;800&amp;quot; |&amp;lt;ref name=&amp;quot;PMID14522813&amp;quot;&amp;gt;American Thoracic Society/European Respiratory Society statement: standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency. Am J Respir Crit Care Med 168(7):818-900 (2003) PMID 14522813 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID1085610&amp;quot;&amp;gt;Alpha 1-antitrypsin deficiency and infantile liver disease. Arch Dis Child 51(8):584-8 (1976) PMID 1085610 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID16874089&amp;quot;&amp;gt;The role of autophagy in alpha-1-antitrypsin deficiency: a specific cellular response in genetic diseases associated with aggregation-prone proteins. Autophagy 2(4):258-63 (2006) PMID 16874089 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID18617899&amp;quot;&amp;gt;Autophagic disposal of the aggregation-prone protein that causes liver inflammation and carcinogenesis in alpha-1-antitrypsin deficiency. Cell Death Differ 16(1):39-45 (2009) PMID 18617899 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID15821195&amp;quot;&amp;gt;Mortality in individuals with severe deficiency of alpha1-antitrypsin: findings from the National Heart, Lung, and Blood Institute Registry. Chest 127(4):1196-204 (2005) PMID 15821195 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID15136365&amp;quot;&amp;gt;Alpha1-antitrypsin deficiency: more than a protease imbalance? Chest 125(5):1607-9 (2004) PMID 15136365 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID12740257&amp;quot;&amp;gt;Augmentation therapy with alpha1-antitrypsin: patterns of use and adverse events. Chest 123(5):1425-34 (2003) PMID 12740257 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID8989160&amp;quot;&amp;gt;Pathogenesis and pathology of liver disease associated with alpha 1-antitrypsin deficiency. Chest 110(6 Suppl):251S-255S (1996) PMID 8989160 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID8989158&amp;quot;&amp;gt;Alpha 1-antitrypsin deficiency. A conformational disease. Chest 110(6 Suppl):243S-247S (1996) PMID 8989158 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID8989157&amp;quot;&amp;gt;A 30-year perspective on alpha 1-antitrypsin deficiency. Chest 110(6 Suppl):237S-242S (1996) PMID 8989157 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID14694355&amp;quot;&amp;gt;Practical genetics: alpha-1-antitrypsin deficiency and the serpinopathies. Eur J Hum Genet 12(3):167-72 (2004) PMID 14694355 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID17264320&amp;quot;&amp;gt;Revisiting alpha1-antitrypsin therapy in cystic fibrosis: can it still offer promise? Eur Respir J 29(2):229-30 (2007) PMID 17264320 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID16264055&amp;quot;&amp;gt;alpha1-Antitrypsin deficiency and lung disease: risk modification by occupational and environmental inhalants. Eur Respir J 26(5):909-17 (2005) PMID 16264055 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID2185272&amp;quot;&amp;gt;Alpha 1-antitrypsin deficiency, emphysema, and liver disease. Genetic basis and strategies for therapy. J Clin Invest 85(5):1343-52 (1990) PMID 2185272 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID3537008&amp;quot;&amp;gt;alpha 1-Antitrypsin: molecular pathology, leukocytes, and tissue damage. J Clin Invest 78(6):1427-31 (1986) PMID 3537008 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID18565211&amp;quot;&amp;gt;Hereditary alpha-1-antitrypsin deficiency and its clinical consequences. Orphanet J Rare Dis 3():16 (2008) PMID 18565211 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID18389391&amp;quot;&amp;gt;Alpha-1 antitrypsin: now available, but do we need it? Swiss Med Wkly 138(13-14):191-6 (2008) PMID 18389391 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID15516477&amp;quot;&amp;gt;Alpha1-antitrypsin deficiency. 7: Computed tomographic imaging in alpha1-antitrypsin deficiency. Thorax 59(11):986-91 (2004) PMID 15516477 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID15454659&amp;quot;&amp;gt;alpha1-Antitrypsin deficiency . 6: new and emerging treatments for alpha1-antitrypsin deficiency. Thorax 59(10):904-9 (2004) PMID 15454659 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID15282394&amp;quot;&amp;gt;alpha1-Antitrypsin deficiency . 5: intravenous augmentation therapy: current understanding. Thorax 59(8):708-12 (2004) PMID 15282394 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID15170041&amp;quot;&amp;gt;Alpha1-antitrypsin deficiency. 4: Molecular pathophysiology. Thorax 59(6):529-35 (2004) PMID 15170041 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID15115878&amp;quot;&amp;gt;Alpha 1-antitrypsin deficiency. 3: Clinical manifestations and natural history. Thorax 59(5):441-5 (2004) PMID 15115878 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID14985567&amp;quot;&amp;gt;Alpha1-antitrypsin deficiency. 2: genetic aspects of alpha(1)-antitrypsin deficiency: phenotypes and genetic modifiers of emphysema risk. Thorax 59(3):259-64 (2004) PMID 14985567 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID3321708&amp;quot;&amp;gt;Association of alpha 1-antitrypsin deficiency with lung and liver diseases. West J Med 147(1):48-53 (1987) PMID 3321708 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID17464974&amp;quot;&amp;gt;Molecular pathogenesis of alpha-1-antitrypsin deficiency-associated liver disease: a meeting review. Hepatology 45(5):1313-23 (2007) PMID 17464974 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID8938188&amp;quot;&amp;gt;Molecular pathogenesis of liver disease in alpha1-antitrypsin deficiency. Hepatology 24(6):1504-16 (1996) PMID 8938188 &amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;#dfdfdf&amp;quot; | &amp;#039;&amp;#039;&amp;#039;Wichtige Übersichtsartikel&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
| align=&amp;quot;left&amp;quot; width=&amp;quot;800&amp;quot;| &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;#dfdfdf&amp;quot; | &amp;#039;&amp;#039;&amp;#039;Medline Suchterm/ Synonyme&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
| align=&amp;quot;left&amp;quot; width=&amp;quot;800&amp;quot;| &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;#00dfdf&amp;quot; | &amp;#039;&amp;#039;&amp;#039;Was ist das&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
| align=&amp;quot;left&amp;quot; width=&amp;quot;800&amp;quot;| &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;#dfdfdf&amp;quot; | &amp;#039;&amp;#039;&amp;#039;Struktur&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
| align=&amp;quot;left&amp;quot; width=&amp;quot;800&amp;quot;| &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;#dfdfdf&amp;quot; | &amp;#039;&amp;#039;&amp;#039;Physiologie&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
| align=&amp;quot;left&amp;quot; width=&amp;quot;800&amp;quot;| &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;#dfdfdf&amp;quot; | &amp;#039;&amp;#039;&amp;#039;Knockout&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
| align=&amp;quot;left&amp;quot; width=&amp;quot;800&amp;quot;| &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;#dfdfdf&amp;quot; | &amp;#039;&amp;#039;&amp;#039;Transgen&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
| align=&amp;quot;left&amp;quot; width=&amp;quot;800&amp;quot;| &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;#dfdfdf&amp;quot; | &amp;#039;&amp;#039;&amp;#039;Mutation&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
| align=&amp;quot;left&amp;quot; width=&amp;quot;800&amp;quot;| &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;#dfdfdf&amp;quot; | &amp;#039;&amp;#039;&amp;#039;Polymorphismus&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
| align=&amp;quot;left&amp;quot; width=&amp;quot;800&amp;quot;| &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;#dfdfdf&amp;quot; | &amp;#039;&amp;#039;&amp;#039;Genexpression&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
| align=&amp;quot;left&amp;quot; width=&amp;quot;800&amp;quot;| &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;#dfdfdf&amp;quot; | &amp;#039;&amp;#039;&amp;#039;Inhibitoren&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
| align=&amp;quot;left&amp;quot; width=&amp;quot;800&amp;quot;| &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;#dfdfdf&amp;quot; | &amp;#039;&amp;#039;&amp;#039;Agonisten&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
| align=&amp;quot;left&amp;quot; width=&amp;quot;800&amp;quot;| &lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== Bibliographie ==&lt;br /&gt;
&amp;lt;references /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
{{LinkWP_Miniartikel}}&lt;/div&gt;</summary>
		<author><name>Ossip Groth</name></author>
	</entry>
</feed>